Skip to main content
Neoadjuvant durvalumab does not affect surgical outcomes in NSCLC: Study
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Neoadjuvant durvalumab does not affect surgical outcomes in NSCLC: Study
User login
Username
Password
Reset your password
Concept
Lead
score
Non-Small Cell Lung Cancer
1
1
Lung Cancer
0
0.95
Surgery
0
0.99
Neoadjuvant Therapy
0
0.98
Perioperative Care
0
0.19
Polymerase Chain Reaction
0
0.19
Small Cell Lung Cancer
0
0.15
Chemotherapy
0
0.14
Combination Chemotherapy
0
0.14
Tumor
0
0.14
Biologic Therapy
0
0.11
Cancer
0
0.1
Lung
0
0.1
Resection
0
0.1
Lymph Node Dissection
0
0.07
Specialty
Lead
score
Hematology-Oncology
1
1
Pharmacist
0
0.8
Pulmonary Medicine
0
0.7
General Surgery
0
0.9
Edit Tags